Siemens Healthineers Opens Innovation Center in Erlangen

Siemens HealthineersSiemens Healthineers has opened its new Innovation Center in Erlangen, Germany, in the heart of the regional medical technology research area known as Medical Valley. The focus is on open innovation by collaborating with external partner companies, start-ups and academic and clinical institutions to improve healthcare worldwide. The innovation center complements an existing ecosystem of centers in Shanghai, China, and Bengaluru, India. The underpinning idea is to create an infrastructure to strengthen innovation across the region, promote open collaboration in research, development and production, and enable customer- and market-oriented development.

"With our new Innovation Center, we are highlighting our commitment to the Erlangen and Forchheim locations and continuing to consistently implement our strategy of an open innovation culture," said Peter Schardt, Chief Technology Officer (CTO) of Siemens Healthineers. "The goal is to jointly focus on new technologies and value-added processes that have the potential to disrupt the healthcare system for the benefit of patients. By promoting open collaborations and projects, Siemens Healthineers and its customers will enable more people around the world to access high-quality medical care - from precise diagnosis to the right therapy."

Among other things, the company’s ASOR community has a co-working space in the new premises to further advance research and development for extended reality applications with internal and external partner companies, and to make digital content more tangible. Specifically, the aim is to test and develop prototypes and to virtually simulate medical technology solutions and applications, for example for training.

The Innovation Center is also home to partnerships such as the digital health innovation platform d.hip, an alliance of industry, university medicine and research organizations which aims to advance the digitization of the healthcare system.

In fiscal 2022 Siemens Healthineers invested around €1.8 billion in research and development and holds around 23,000 technical property rights, including around 15,000 granted patents.

About Siemens Healthineers

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies are continuously developing their product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company's foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers' ability to provide high-quality, efficient care. In fiscal 2022, which ended on September 30, 2022, Siemens Healthineers, which has approximately 69,500 employees worldwide, generated revenue of around €21.7 billion and adjusted EBIT of almost €3.7 billion.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Should AI Chatbots Replace Your Therapis…

The new study exposes the dangerous flaws in using artificial intelligence (AI) chatbots for mental health support. For the first time, the researchers evaluated these AI systems against clinical standards...

NHS National Rehabilitation Centre to De…

The new NHS National Rehabilitation Centre will deploy technology to help patients to maintain their independence as they recover from life-changing injuries and illnesses and regain quality of life. Airwave Healthcare...

Meet Your Digital Twin

Before an important meeting or when a big decision needs to be made, we often mentally run through various scenarios before settling on the best course of action. But when...

AI Finds Hundreds of Potential Antibioti…

Snake, scorpion, and spider venom are most frequently associated with poisonous bites, but with the help of artificial intelligence, they might be able to help fight antibiotic resistance, which contributes...

AI Tool Accurately Detects Tumor Locatio…

An AI model trained to detect abnormalities on breast MR images accurately depicted tumor locations and outperformed benchmark models when tested in three different groups, according to a study published...

AI can Accelerate Search for More Effect…

Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer’s disease drug. They found the drug slowed cognitive decline by 46% in...

AI Accurately Classifies Pancreatic Cyst…

Artificial intelligence (AI) models such as ChatGPT are designed to rapidly process data. Using the AI ChatGPT-4 platform to extract and analyze specific data points from the Magnetic Resonance Imaging...

Free AI Tools can Help Doctors Read Medi…

A new study from the University of Colorado Anschutz Medical Campus shows that free, open-source artificial intelligence (AI) tools can help doctors report medical scans just as well as more...

Autonomous AI Agents in Healthcare

The use of large language models (LLMs) and other forms of generative AI (GenAI) in healthcare has surged in recent years, and many of these technologies are already applied in...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Can Amazon Alexa or Google Home Help Det…

Computer scientists at the University of Rochester have developed an AI-powered, speech-based screening tool that can help people assess whether they are showing signs of Parkinson’s disease, the fastest growing...